TY  - JOUR 
AU  - Pedicona, Federico
AU  - Casado, Pedro
AU  - Hijazi Vega, Maruan
AU  - Gribben, John G
AU  - Rouault-Pierre, Kevin
AU  - Cutillas, Pedro R
PY  - 2022
UR  - http://hdl.handle.net/10366/161299
AB  - [EN]Most tumor types either fail to respond or become resistant to kinase inhibitors, often because of compensatory prosurvival pathways in the cancer cell's broader signaling circuitry. Here, we found that intrinsic resistance to kinase inhibitors in...
LA  - eng
PB  - American Association for the Advancement of Science
KW  - Antineoplastic Agents
KW  - Leukemia Myeloid Acute
KW  - Histone Demethylases
KW  - Lysine
KW  - Mitogen Activated Protein Kinase Kinases
KW  - Protein Kinase Inhibitors
KW  - Mitogen-Activated Protein Kinase Kinases
KW  - Histone Demethylases
KW  - Leukemia
KW  - Humans
KW  - Lysine
KW  - Cell Line
KW  - Antineoplastic Agents
KW  - Protein Kinase Inhibitors
TI  - Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment.
DO  - 10.1126/scisignal.abl7989
T2  - Science Signaling
VL  - 15
M2  - eabl7989
ER  -